Abstract
Erythrocytes have been proposed and utilized as carriers for drugs, enzymes and pharmacological agents.1–13 Carrier erythrocytes have the capacity to enhance drug efficacy, extend the pharmacological life span of the drug, and reduce toxic side effects. Hypotonic dialysis has been used to prepare carriers that have a high percentage of encapsulation and cell recovery, and a normal survival when they are reinjected into the animal.1,2
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
G. Dale, D.G. Villacorta and E. Beutler, High-yield entrapment of proteins into erythrocytes, Biochem.Med. 18:220 (1977).
J.R. DeLoach and G.M. Ihler, A dialysis procedure for loading erythrocytes with enzyme and lipids, Biochem.Biophys.Acta 496:136 (1977).
S.J. Updike, R.T. Wakamiya and E.N. Lightfoot, Asparaginase entrapped in red blood cells:Action and survival. Science 193:681 (1976).
A.R. Hubbard, U. Sprandel and R.A. Chalmers, Dependence of mouse erythrocyte “ghosts” survival on cellular ATP concentration, Biochem.Soc.Trans. 8:578 (1980).
J.R. DeLoach, G.G. Wagner and T.M. Craig, Imidocarb dipropinate encapsulation and binding to resealed carrier bovine erythrocytes for potential babesiosis chemotherapy, J.Appl.Biochem. 3:254 (1981).
E. Beutler, G. Dale, E. Guinto and N. Kuhl, Enzyme replacement therapy in Gaucher’s disease:Preliminary clinical trial of a new enzyme preparation, Proc.Natl. Acad.Sci.USA 74:4620 (1977).
S.J. Updike and R.T. Wakamiya, Infusion of red blood cell-loaded asparaginase in monkey, J.Lab.Clin.Med. 101:679 (1983).
R. Green, J. Lamon and D. Curran, Clinical trial of desferrioxamine entrapped in red blood cell ghosts, Lancet 3:327 (1980).
C. Ropars, M. Chassaigne, M.C. Villereal, G. Avenard, C. Hurel and C. Nicolau, Resealed red blood cell as a new blood transfusion product, in “Red Blood Cell as Carrier for Drug”, Bibliotheca Haematologica, J.R. DeLoach, U.Sprandel ed., Karger, Basel (1985).
G.G. Wagner, D.E. Cornier and J.R. DeLoach, Erythrocytes drug carriers for babesiosis chemotherapy, J.Contr. Release 8:79 (1988).
B.P. Tesseire, C. Ropars, M.O. Vallez, R.A. Herigault and C. Nicolau, Physiological effect of high P50 red cell transfusion on piglets, J.Appl.Physiol. 58:1810 (1985).
C. Ropars, G. Avenard and M. Chassaigne, Large-scale entrapment of drug into resealed red blood cell using a continuous flow dialysis system, in “Methods in Enzymology”, R.Green, K.J.Widder ed., Academic Press, San Diego (1987).
G. Dale, High-efficiency entrapment of enzyme in resealed red blood cell ghost by dialysis, in “Methods in Enzymology”, R.Green, K.J.Widder ed., Academic Press, San Diego (1987).
J.R. DeLoach, Dialysis method for entrapment of protein into resealed red blood cell, in “Methods in Enzymology” R. Green, K.J. Widder ed., Academic Press, San Diego (1987).
H.T. Meryman, M.L. Hornblower and R.L. Syring, Prolonged storage of red cell at 4°C, Transfusion 26:500 (1986).
J.A. Silbert, The storage of washed human erythrocytes in a protein free medium,Transfusion 23:8 (1983).
J.R. DeLoach and R. Droleskey, Survival of murine erythrocytes injected via the peritoneum, Comp.Biochem. Physiol. 84A: 447 (1986).
E. Zocchi, M. Tonetti, C. Polvani, U. Benatti and A. De Flora, In vivo and lung targeting of adriamycin encapsulated in glutaraldehyde-treated murine erythrocytes, Biotechnol.Appl.Biochem. 10:555 (1988).
E. Zocchi, L. Guida, U. Benatti, M. Canepa, L. Borgiani, T. Zanin and A. De Flora, Hepatic or splenic targeting of carrier erythrocytes: a murine model, Biotechnol. Appl.Biochem. 9:443 (1987).
H.O. Alpar and A.D. Lewis, The prolongation of the survival time of mice implanted with TLX5 cells by treatment with methotrexate encapsulated in erythrocytes. Biochem.Pharmacol. 36:3081 (1987).
J.R. DeLoach and K. Andrews, Stability of membrane pores in hypotonically dialyzed erythrocytes: Coencapsulation of different stokes radius probes can occur for at least 21 days in human erythrocytes, Biotechnol.Appl. Biochem. 8:537 (1986).
L. Chiarantini, J. Johnson and J.R. DeLoach, Optimized recirculation survival of mouse carrier erythrocytes, Blood Cells 17:607 (1991).
J.R. DeLoach and K. Andrews, Carrier erythrocytes from cattle can be prepared from cells stored in a hypotonic, porous, dialyzed state. Biotechnol.Appl.Biochem. 9:443 (1987).
J.R. DeLoach and K. Andrews, Membrane pores in hypotonically dialyzed sheep erythrocytes remain open after three weeks of storage: entrapment of different strokes radius probes, 14C-sucrose 3H-inulin, Biotechnol.Appl.Biochem. 8:546 (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chiarantini, L., DeLoach, J.R. (1992). Standardization of an Encapsulation System: A Method to Remove Fragile Cells. In: Magnani, M., DeLoach, J.R. (eds) The Use of Resealed Erythrocytes as Carriers and Bioreactors. Advances in Experimental Medicine and Biology, vol 326. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3030-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3030-5_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6321-7
Online ISBN: 978-1-4615-3030-5
eBook Packages: Springer Book Archive